Tyce Gm

653 total citations
17 papers, 549 citations indexed

About

Tyce Gm is a scholar working on Neurology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, Tyce Gm has authored 17 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Clinical Biochemistry. Recurrent topics in Tyce Gm's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Metabolism and Genetic Disorders (3 papers) and Neurological disorders and treatments (3 papers). Tyce Gm is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Metabolism and Genetic Disorders (3 papers) and Neurological disorders and treatments (3 papers). Tyce Gm collaborates with scholars based in United States. Tyce Gm's co-authors include Muenter, Donna L. Hammond, Owen Ca, Fúster, Shepherd Jt, Vanhoutte Pm, van Heerden Ja, Richard W. Bianco, Kaye Mp and Ernesto Solis and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Tyce Gm

16 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tyce Gm United States 11 388 213 102 54 47 17 549
P. F. Teychenne United Kingdom 13 354 0.9× 186 0.9× 53 0.5× 77 1.4× 34 0.7× 17 661
Albert Goodgold United States 9 462 1.2× 124 0.6× 62 0.6× 42 0.8× 85 1.8× 14 611
G. Scigliano Italy 14 490 1.3× 248 1.2× 64 0.6× 108 2.0× 49 1.0× 29 684
S Düby United States 7 209 0.5× 98 0.5× 38 0.4× 43 0.8× 23 0.5× 9 405
S. Bassi Italy 10 157 0.4× 143 0.7× 71 0.7× 88 1.6× 35 0.7× 26 391
Gianna Gambaccini Italy 10 360 0.9× 155 0.7× 29 0.3× 42 0.8× 49 1.0× 10 454
John J. Grome United Kingdom 11 100 0.3× 173 0.8× 72 0.7× 97 1.8× 41 0.9× 15 384
Francisco Cabrera‐Valdivia Spain 14 378 1.0× 95 0.4× 104 1.0× 63 1.2× 29 0.6× 30 558
T. Siirtola Finland 9 201 0.5× 109 0.5× 35 0.3× 25 0.5× 35 0.7× 19 329
S. Wenger Austria 8 418 1.1× 273 1.3× 30 0.3× 58 1.1× 61 1.3× 11 599

Countries citing papers authored by Tyce Gm

Since Specialization
Citations

This map shows the geographic impact of Tyce Gm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyce Gm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyce Gm more than expected).

Fields of papers citing papers by Tyce Gm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyce Gm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyce Gm. The network helps show where Tyce Gm may publish in the future.

Co-authorship network of co-authors of Tyce Gm

This figure shows the co-authorship network connecting the top 25 collaborators of Tyce Gm. A scholar is included among the top collaborators of Tyce Gm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyce Gm. Tyce Gm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gm, Tyce, et al.. (1989). Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats.. PubMed. 27(2). 139–54. 2 indexed citations
2.
Gm, Tyce, et al.. (1989). Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease.. PubMed. 114(2). 185–92. 17 indexed citations
3.
Solis, Ernesto, Tyce Gm, Richard W. Bianco, Jolonda C. Mahoney, & Kaye Mp. (1987). High energy phosphates and catecholamine stores after prolonged ex vivo heart preservation.. PubMed. 5(6). 444–9. 4 indexed citations
4.
Hammond, Donna L., et al.. (1981). Functional aspects of bulbospinal monoaminergic projections in modulating processing of somatosensory information.. PubMed. 40(13). 2786–94. 76 indexed citations
5.
Gm, Tyce, et al.. (1981). Release of norepinephrine and serotonin in cat spinal cord: direct in vivo evidence for the activation of descending monoamine pathways by somatic stimulation.. PubMed. 77(2-3). 483–7. 16 indexed citations
6.
Gm, Tyce, Fúster, & Owen Ca. (1979). Dipyridamole levels in plasma of man and other species.. PubMed. 26(3). 495–508. 13 indexed citations
7.
Jt, Shepherd, et al.. (1978). Acetylcholine--inhibition of transmitter release from adrenergic nerve terminals mediated by muscarinic receptors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(2). 191–194. 14 indexed citations
8.
Gm, Tyce, et al.. (1977). The carcinoid syndrome--a role for hemodialysis.. PubMed. 61(1). 107–8. 1 indexed citations
9.
Gm, Tyce. (1977). Demethylation of O-methyl metabolites of catecholamines in erythrocytes: a methanol-forming reaction.. PubMed. 16(4). 669–85. 1 indexed citations
10.
Muenter, et al.. (1977). Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease.. PubMed. 52(3). 163–74. 119 indexed citations
11.
Gm, Tyce, et al.. (1974). Demethylation of 3-methoxy-4-hydroxyphenylalanine in the isolated perfused rat liver.. PubMed. 5. 327–9. 1 indexed citations
12.
Muenter, et al.. (1974). 3-O-Methyldopa in Parkinson's disease.. PubMed. 5. 309–15. 16 indexed citations
13.
Muenter, et al.. (1973). 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.. PubMed. 48(3). 173–83. 23 indexed citations
14.
Muenter, et al.. (1972). Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.. PubMed. 47(6). 389–95. 17 indexed citations
15.
Muenter & Tyce Gm. (1971). L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.. PubMed. 46(4). 231–9. 207 indexed citations
16.
Gm, Tyce, Muenter, & Owen Ca. (1970). Dihydroxyphenylalanine (DOPA) in plasma during dopa treatment of patients with Parkinson's disease.. PubMed. 45(6). 438–43. 13 indexed citations
17.
Gm, Tyce, Muenter, & Owen Ca. (1970). Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.. PubMed. 45(9). 645–56. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026